Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

On the heels of President Donald Trump’s Monday announcement of an executive order that will slash prescription drug prices ...

Novo Nordisk’s Wegovy (semaglutide injection) 2.4mg has demonstrated early protection against heart disease, according to new ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening steatohepatitis.

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.